Compare Stocks: GCTK, INBS, SONX, and AMIX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$4.28 +3.9%	$5.74	$2.44 ▼ $32.55	$4.00M	-1	2.41 million shs	67,100 shs
GCTK GlucoTrack	$2.38 +6.3%	$5.15	$2.18 ▼ $136.29	$1.58M	0.62	100,505 shs	18,728 shs
INBS Intelligent Bio Solutions	$2.00 +1.5%	$2.19	$1.52 ▼ $24.90	$6.53M	4.25	311,031 shs	26,351 shs
SONX Sonendo	$1.30	$0.95	$0.02 ▼ $1.30	$6.21M	1.81	1,274 shs	N/A

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+3.88%	-2.51%	-30.63%	-44.92%	-82.43%
GCTK GlucoTrack	+6.25%	-26.32%	-54.01%	-56.94%	-97.90%
INBS Intelligent Bio Solutions	+1.52%	-8.68%	-37.89%	-12.66%	-85.82%
SONX Sonendo	0.00%	+18.18%	+136.36%	+116.67%	+420.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$4.28 +3.9%	$5.74	$2.44 ▼ $32.55	$4.00M	-1	2.41 million shs	67,100 shs
GCTK GlucoTrack	$2.38 +6.3%	$5.15	$2.18 ▼ $136.29	$1.58M	0.62	100,505 shs	18,728 shs
INBS Intelligent Bio Solutions	$2.00 +1.5%	$2.19	$1.52 ▼ $24.90	$6.53M	4.25	311,031 shs	26,351 shs
SONX Sonendo	$1.30	$0.95	$0.02 ▼ $1.30	$6.21M	1.81	1,274 shs	N/A

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+3.88%	-2.51%	-30.63%	-44.92%	-82.43%
GCTK GlucoTrack	+6.25%	-26.32%	-54.01%	-56.94%	-97.90%
INBS Intelligent Bio Solutions	+1.52%	-8.68%	-37.89%	-12.66%	-85.82%
SONX Sonendo	0.00%	+18.18%	+136.36%	+116.67%	+420.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	2.00	Hold	$42.00	881.31% Upside
GCTK GlucoTrack	1.00	Sell	N/A	N/A
INBS Intelligent Bio Solutions	1.50	Reduce	N/A	N/A
SONX Sonendo	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest GCTK, INBS, SONX, and AMIX Analyst Ratings

Date	Company	Brokerage	Action	Rating
7/28/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/17/2026	GCTK GlucoTrack	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	INBS Intelligent Bio Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/10/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/29/2026	INBS Intelligent Bio Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/23/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)

(Data available from 9/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$10.85 per share	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$41.93 per share	N/A
INBS Intelligent Bio Solutions	$4.22M	1.57	N/A	N/A	$2.21 per share	0.90
SONX Sonendo	$44.40M	0.14	N/A	N/A	$89.42 per share	0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$16.72M	-$41.57	N/A	N/A	N/A	N/A	-267.73%	-216.75%	11/11/2026 (Estimated)
GCTK GlucoTrack	-$19.39M	-$137.63	N/A	N/A	N/A	N/A	-2,135.52%	-290.22%	N/A
INBS Intelligent Bio Solutions	-$12.43M	-$9.02	N/A	N/A	N/A	-294.88%	-175.35%	-91.25%	11/11/2026 (Estimated)
SONX Sonendo	-$60.92M	-$71.12	N/A	N/A	N/A	-92.74%	-184.01%	-68.60%	11/11/2026 (Estimated)

Latest GCTK, INBS, SONX, and AMIX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/19/2026	Q4 2026	INBS Intelligent Bio Solutions	-$1.58	-$0.90	+$0.68	-$0.90	$1.22 million	$1.15 million
8/12/2026	Q1 2027	AMIX Autonomix Medical	-$6.40	-$5.02	+$1.38	-$5.02	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
INBS Intelligent Bio Solutions	N/A	N/A	N/A	N/A	N/A
SONX Sonendo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	4.85	4.85
GCTK GlucoTrack	0.08	0.46	0.46
INBS Intelligent Bio Solutions	N/A	1.44	1.35
SONX Sonendo	0.55	1.82	1.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
GCTK GlucoTrack	10.92%
INBS Intelligent Bio Solutions	32.97%
SONX Sonendo	28.68%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	6.20%
GCTK GlucoTrack	5.90%
INBS Intelligent Bio Solutions	1.27%
SONX Sonendo	7.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	971,000	911,000	N/A
GCTK GlucoTrack	5	710,000	664,000	Not Optionable
INBS Intelligent Bio Solutions	10	3.32 million	2.99 million	Not Optionable
SONX Sonendo	250	4.78 million	393,000	Not Optionable

GCTK, INBS, SONX, and AMIX Headlines

Recent News About These Companies

Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even

August 25, 2026 | businesswire.com

Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024

June 26, 2026 | businesswire.com

Sonendo Stock Price, Quotes and Forecasts | OTC:SONX | Benzinga

April 8, 2026 | benzinga.com

Sonendo, Inc. on Path to Breakeven in the Second Half of 2026

March 16, 2026 | businesswire.com

Sonendo Strengthens Leadership Team With Promotion of John McGaugh to ...

August 22, 2025 | businesswire.com

Sonendo names John McGaugh COO

August 20, 2025 | msn.com

Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer

August 20, 2025 | businesswire.com

Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance

August 13, 2025 | businesswire.com

Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance

June 4, 2025 | businesswire.com

Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

March 26, 2025 | businesswire.com

Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024

November 11, 2024 | businesswire.com

Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

November 5, 2024 | zacks.com

Sonendo Launches ProControlTM for the GentleWave® G4 System

October 23, 2024 | businesswire.com

Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results

October 10, 2024 | businesswire.com

BIOLASE files for Chapter 11, plans asset sale to Sonendo

October 3, 2024 | investing.com

Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now

August 27, 2024 | zacks.com

Sonendo Inc.

August 17, 2024 | marketwatch.com

Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript

August 10, 2024 | seekingalpha.com

Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2024 | zacks.com

Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance

August 7, 2024 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GCTK, INBS, SONX, and AMIX Company Descriptions

Autonomix Medical NASDAQ:AMIX

$4.28 +0.16 (+3.88%)

Closing price 09/17/2026 04:00 PM Eastern

Extended Trading

$4.38 +0.10 (+2.34%)

As of 08:41 AM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

GlucoTrack NASDAQ:GCTK

$2.38 +0.14 (+6.25%)

Closing price 09/17/2026 04:00 PM Eastern

Extended Trading

$2.42 +0.04 (+1.89%)

As of 08:40 AM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Intelligent Bio Solutions NASDAQ:INBS

$2.00 +0.03 (+1.52%)

Closing price 09/17/2026 03:59 PM Eastern

Extended Trading

$2.01 +0.01 (+0.35%)

As of 05:35 AM Eastern

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Sonendo NYSE:SONX

$1.30 0.00 (0.00%)

As of 09/16/2026

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GCTK, INBS, SONX, and AMIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GCTK, INBS, SONX, and AMIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GCTK, INBS, SONX, and AMIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GCTK, INBS, SONX, and AMIX Company Descriptions

Autonomix Medical NASDAQ:AMIX

GlucoTrack NASDAQ:GCTK

Intelligent Bio Solutions NASDAQ:INBS

Sonendo NYSE:SONX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GCTK, INBS, SONX, and AMIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GCTK, INBS, SONX, and AMIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GCTK, INBS, SONX, and AMIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GCTK, INBS, SONX, and AMIX Company Descriptions

Autonomix Medical NASDAQ:AMIX

GlucoTrack NASDAQ:GCTK

Intelligent Bio Solutions NASDAQ:INBS

Sonendo NYSE:SONX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools